Krystal Biotech Unearned Premium on Insurance Contract (Quarterly) Analysis

Krystal Biotech, Inc. (KRYS)

267.05 -7.54 (-2.75%) USD | NASDAQ | Feb 24, 11:06

View Unearned Premium on Insurance Contract (Quarterly) for KRYS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unearned Premium on Insurance Contract (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unearned Premium on Insurance Contract (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unearned Premium on Insurance Contract (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	--
DexCom, Inc.	--
Alkermes Plc	--
Regeneron Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--